PointState Capital’s Momenta Pharmaceuticals MNTA Stock Holding History
Bought
Maintained
Sold
Other funds holding MNTA
PointState Capital's MNTA Position: Q3 2015 in Review
PointState Capital sold out of Momenta Pharmaceuticals (MNTA) in Q3 2015, closing a stake of 24,834 shares — an estimated $566K sold.
PointState Capital first reported a position in MNTA in Q4 2013 and held it in 2 quarters. The position peaked at $6.19M in Q4 2013. 156 funds tracked by Wall St. Rank hold MNTA as of Q3 2015.
- PointState Capital reported no remaining Momenta Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
- PointState Capital sold 24,834 Momenta Pharmaceuticals shares in Q3 2015, an estimated $566K.
- PointState Capital first reported a position in Momenta Pharmaceuticals in Q4 2013 and held it in 2 quarters.
- PointState Capital's Momenta Pharmaceuticals position peaked at $6.19M in Q4 2013.
- 156 funds tracked by Wall St. Rank held Momenta Pharmaceuticals as of Q3 2015.
Based on PointState Capital's 13F filing for Q3 2015, filed 16 Nov 2015.